News | Point-of-Care Ultrasound (POCUS) | October 16, 2025

Next evolution of Venue family features new digital tools to assist users in conducting exams with increased confidence and less complexity.

Photo: GE Healthcare


Oct. 15, 2025 — GE HealthCare has announced the latest advancement in its Venue family of point-of-care ultrasound (POCUS) systems, now enhanced with new artificial intelligence (AI)-enabled and digital tools designed to boost confidence and efficiency. New tools include Nerveblox, an AI-enabled feature that automatically labels anatomical landmarks in the ultrasound image, designed to help clinicians feel confident during the peripheral nerve block procedure and streamline the workflow.

Additional AI-enabled and digital tools aim to simplify bladder volume measurements, and support complex and advanced ultrasound exams in the point of care setting. These enhancements extend across the entire Venue portfolio, including Venue, Venue Go, Venue Fit and Venue Sprint. 

“Our ultrasound portfolio is continuously evolving to meet the dynamic needs of clinicians, and we’re committed to driving innovation that makes our solutions more versatile, adaptable and impactful,” said Karley Yoder, CEO of Comprehensive Care Ultrasound, Advanced Visualization Solutions at GE HealthCare. “With the latest Venue family systems, we’re proud to add new tools that enhance the use of POCUS in anesthesiology and pain management and enhance other tools and features that empower clinicians across all experience levels to deliver confident care anytime, anywhere.” 

POCUS is designed to transform care by allowing clinicians to make faster, more confident decisions using real-time imaging across a wide variety of care scenarios.  These ultrasound systems can be found in emergency, critical care, anesthesia and other clinical settings to guide diagnosis and procedures. In anesthesia, ultrasound is increasingly used to enhance visualization during procedures such as regional blocks and vascular access, intended to support precision and patient safety.  

To support this evolving application, Venue family ultrasound systems incorporate AI-enabled features to assist clinicians in performing safe procedures. To advance anesthesiology care, a new AI feature, Nerveblox, is available to automatically label key anatomical landmarks in the ultrasound image and has demonstrated a 97% anatomical structure identification accuracy.i With this technology, Venue ultrasound systems support a broad range of nerve blocks, assisting clinicians with conducting 12 of the most common types of regional anesthesia procedures. This solution aims to help clinicians feel confident during the procedure, streamline workflow and reduce procedure time.  

“Nerveblox immediately impressed me. It provides a clear, colorful image of the target area in less than a second for multiple nerve blocks,” said Dr. Olivier Choquet, Montpellier University Hospital, France. “I tested it with different approaches, and its performance should be excellent in helping the practitioner locate key anatomical structures before inserting the needle. This feature is truly impressive.”    

The latest Venue family ultrasound systems introduce advanced imaging modes and new AI-enabled tools that can simplify the scanning process, enhance speed and accuracy during assessments and decision making, including: 

  • Contrast Enhanced Ultrasound, an advanced imaging mode that enables dynamic bedside evaluation of abdominal injuries and lesions.  

  • Auto Bladder Volume, which simplifies urinary bladder volume measurement from two views, reducing exam clicks. This feature is also now available on the wireless Vscan Air™ CL probe that can also connect to the Venue family systems. 

  • For cardiac assessments, Automated Function Imaging provides objective analysis of myocardial strain across heart chambers. In addition to the existing Caption Guidance™ AI-enabled software, which provides turn-by-turn, on-screen guidance to help expert and non-expert users capture diagnostic-quality cardiac ultrasound images. 

The latest Venue family ultrasound systems are U.S. FDA cleared and CE Marked for the European Union and are available in other markets where regulatory approval has been granted.

For more information, visit: www.gehealthcare.com/products/ultrasound/venue-family/venue-family-innovation


Related Content

Feature | Artificial Intelligence

For the past decade, artificial intelligence's (AI) potential in healthcare has been synonymous with speed. In medical ...

Time February 16, 2026
arrow
News | Radiology Imaging

Feb. 12, 2026 — Siemens Healthineers and Mayo Clinic are expanding their strategic collaboration to enhance patient care ...

Time February 13, 2026
arrow
News | ARRS

Feb. 11, 2026 —The American Roentgen Ray Society (ARRS) has announced the following radiologists, as well as their ...

Time February 13, 2026
arrow
News | Radiology Business

Feb. 3, 2026 — RadNet, Inc., a provider of high-quality, cost-effective outpatient diagnostic imaging services and ...

Time February 12, 2026
arrow
Feature | Cardiac Imaging | Kyle Hardner

Advances in coronary CT angiography (CCTA) have reached the point where image quality and AI capabilities are creating ...

Time February 06, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

Feb. 6, 2026 — A state-of-the-art intraoperative MRI (iMRI) has arrived at the University of Chicago Medicine, one of ...

Time February 06, 2026
arrow
News | Ultrasound Women's Health

Feb. 5, 2026 — BrightHeart, a global provider of AI-driven prenatal ultrasound, has announced the availability of its B ...

Time February 05, 2026
arrow
News | Lung Imaging

Feb. 3, 2026 — RevealDx, a leader in the characterization of lung nodules, recently announced FDA clearance of RevealAI ...

Time February 04, 2026
arrow
News | Computed Tomography (CT)

Feb. 4, 2026 — A new review published in the American Journal of Roentgenology (AJR) finds that advances in CT ...

Time February 04, 2026
arrow
News | Radiology Imaging

Feb. 4, 2026 — The Royal College of Radiologists (RCR) has issued its initial reaction to the British government's ...

Time February 04, 2026
arrow
Subscribe Now